A CROSS-SECTIONAL STUDY OF USE OF IRON SUPPLEMENTS IN CHILDREN WITH ANEMIA

Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 6

Abstract

Objectives: Iron deficiency (ID) is the most common nutritional problem in the world and is the most common cause of childhood anemia. In this study, our aim was to find out about the state of usage of iron preparation, which is distributed free of charge by the Ministry of Health, for the infants between 4-12 months in our country, as well as detecting the awareness degree of families those who are informed about iron-deficiency anemia (IDA), prophylaxis of the drug and to determine the drug’s effectiveness. Methods: It was a cross-sectional survey. The laboratory values from the files of the children aged 1-2 those who visited our hospital’s department of pediatrics, between January 2010 to August 2013, were collected. The survey included families who have children diagnosed with IDA. Questions included about families’ sociodemographic characteristics, the state of the usage of the iron drug, how much information received in terms of the side effects-consumption period and dosage. Results: A total of 139 children were enrolled in our study. While 77.7% of the families who participated stated that (n = 108) iron medicine was prescribed other 43.2% of families stated (n = 60) was prescribed and they were informed about iron pills and IDA. 25.9% of families had received information about drug’s side effects, 74.8% of them had information about period of consumption and 77.7% said they were given information about the drug dose. The average duration of use of iron medicine was 6.98±4.52 (min: 1, max: 24) months. It has been noted that; parent’s education level, mother’s occupation, child’s gender, how the child was born and receiving information about how to use the medicine had no effects on usage of the drug in children. Nevertheless, it has been noticed that, when the families were given proper information the drug use increased and the patients compliance with medications also increased. Conclusion: We believe that, due to frequent diagnosis of anemia in children, prophylaxis iron supplementation should be continued for up to the age of two years.

Authors and Affiliations

Dr. Nayab Fatima

Keywords

Related Articles

PATTERN OF UTILIZATION AND METHODS OF PAYMENT FOR HEALTH SERVICES A SOUTH WESTERN CITY OF NIGERIA

Background: The evidence of awareness of public health facilities in rendering qualitative healthcare services has been observed and documented in recent years, but the same cannot be said for its utilization rates. This...

CLINICAL MANIFESTATIONS OF HYPOTHYROIDISM IN RESIDENTS OF RAWALPINDI

Background: This study was designed for the evaluation of the difference in the common signs and symptoms of hypothyroidism in our population from already available literature. Methods: In this study we have compared the...

EFFECTIVE ANTIPYRETIC IN CHILDREN: PARACETAMOL V/S IBUPROFEN AND COMBINATION THERAPY

Febrile child is always a concern for a clinician but it is distressful situation for parents. High temperature in children not only needs treatment but evaluation as well. Antipyretic medications for children with fever...

NEUTROPHIL LYMPHOCYTE RATIO (NLR): A WELL ASSESSMENT TOOL OF GLYCEMIC CONTROL IN TYPE-2 DIABETIC PATIENTS

Background and Objective: Increased neutrophil lymphocyte ratio (NLR) is a marker as well as predictor of various cardiac and non-cardiac disorders. Our aim was to assess the relationship between NLR and different level...

CORRELATION OF DNA DAMAGE IN SEIZURE AND ORGAN DYSFUNCTION OF PERINATAL ASPHYXIA

The present study was conducted to evaluate the level of DNA Damage in Seizure and Organ Dysfunction in Perinatal Asphyxia and its correlation of DNA damage and Organ dysfunction. Eighty term asphyxiated babies were incl...

Download PDF file
  • EP ID EP664713
  • DOI -
  • Views 157
  • Downloads 0

How To Cite

Dr. Nayab Fatima (2018). A CROSS-SECTIONAL STUDY OF USE OF IRON SUPPLEMENTS IN CHILDREN WITH ANEMIA. World Journal of Pharmaceutical and Medical Research, 4(6), 87-92. https://europub.co.uk/articles/-A-664713